Quarterly report pursuant to Section 13 or 15(d)

Supplemental Balance Sheet Information - Schedule of Accrued Expenses and Other Current Liabilities (Details)

v3.24.1.1.u2
Supplemental Balance Sheet Information - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Accrued consulting $ 68,460 $ 49,395
Accrued compensation 325,059 635,451
Accrued research and development 2,088,509 1,472,292
Accrued other 25,561 102,817
Total accrued expenses and other current liabilities $ 2,507,589 $ 2,259,955